Table 1 Clinical and pathological characteristics of included patients.
EpCAM (+) N = 10 | EpCAM (-) N = 30 | Total N = 40 | p-value | |
|---|---|---|---|---|
Age (±SD) | 56.3 (±10.0) | 65.7 (±9.5) | 63.3 (±10.3) | 0.01 |
Gender (M:F) | 5:5 | 18:12 | 23:17 | NS |
pG | NS | |||
1 | 0 | 3 (10.0%) | 3 (7.5%) | |
2 | 2 (20%) | 12 (40.0%) | 14 (35.0%) | |
3 | 8 (80%) | 15 (50.0%) | 23 (57.5%) | |
pT | NS | |||
1 | 0 | 2 (6.7%) | 2 (5.0%) | |
2 | 0 | 4 (13.3%) | 4 (10.0%) | |
3 | 10 (100%) | 24 (80.0%) | 34 (85.0%) | |
pN | NS | |||
0 | 3 (30.0%) | 10 (33.0%) | 13 (32.5%) | |
1 | 7 (70.0%) | 20 (67.0%) | 27 (67.5%) | |
AJCC stage | NS | |||
Stage IA | 0 | 2 (6.7%) | 2 (5.0%) | |
Stage IB | 3 (30.0%) | 8 (26.7%) | 11 (27.5%) | |
Stage IIA | 0 | 1 (3.3%) | 1 (2.5%) | |
Stage IIB | 7 (70.0%) | 18 (60.0%) | 25 (62.5%) | |
Stage III | 0 | 0 | 0 | |
Stage IV | 0 | 1 (3.3%) | 1 (2.5%) | |
ECLNI | NS | |||
0 | 7 (70.0%) | 27 (90.0%) | 34 (85%) | |
1 | 3 (30.0%) | 3 (10.0%) | 6 (15%) | |
Total LN count | 16.5 (10 - 39) | 17 (6 - 35) | 17 (6 - 39) | NS |
LVI * | NS | |||
0 | 3 (33.3%) | 20 (69.0%) | 12 (31.6%) | |
1 | 6 (66.7%) | 9 (31.0%) | 26 (68.4%) | |
PNI | NS | |||
0 | 1 (10.0%) | 7 (23.3%) | 8 (15%) | |
1 | 9 (90.0%) | 23 (76.7%) | 32 (85%) |